⌘K
Loading ticker…
As of 2026-08-24, MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) has a 3-month relative strength percentile of 24 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 41. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.7%, relative volume 0.85×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
MLTX is held by 6 ETFs as of May 2026. Top owner: VHT at 0.01% weight, $2M notional. Top 3 carry $5M.
Held by 14 ETFs · $9M across latest filings · largest weight 0.89% (TMED).
Top 6 by value, from SEC N-PORT-P filings dated May 2026.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.00% |
| $27K |
| — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MLTX Jan avg: 2.54% median: 3.17% win: 50% σ: 16.38% n: 4 2022-04-12 → 2026-07-31 | MLTX Feb avg: 12.37% median: 1.27% win: 50% σ: 34.00% n: 4 2022-04-12 → 2026-07-31 | MLTX Mar avg: 3.90% median: 5.29% win: 75% σ: 7.54% n: 4 2022-04-12 → 2026-07-31 | MLTX Apr avg: -6.20% median: -7.60% win: 20% σ: 10.20% n: 5 2022-04-12 → 2026-07-31 | MLTX May avg: 12.32% median: 17.09% win: 60% σ: 15.54% n: 5 2022-04-12 → 2026-07-31 | MLTX Jun avg: 17.20% median: 8.14% win: 80% σ: 43.89% n: 5 2022-04-12 → 2026-07-31 | MLTX Jul avg: 7.11% median: 6.86% win: 60% σ: 12.45% n: 5 2022-04-12 → 2026-07-31 | MLTX Aug avg: 11.37% median: 11.43% win: 75% σ: 13.60% n: 4 2022-04-12 → 2026-07-31 (current) | MLTX Sep avg: -21.02% median: -2.36% win: 25% σ: 44.35% n: 4 2022-04-12 → 2026-07-31 | MLTX Oct avg: 7.50% median: -0.87% win: 50% σ: 23.30% n: 4 2022-04-12 → 2026-07-31 | MLTX Nov avg: 14.61% median: 18.88% win: 75% σ: 21.51% n: 4 2022-04-12 → 2026-07-31 | MLTX Dec avg: 9.69% median: 2.61% win: 50% σ: 19.00% n: 4 2022-04-12 → 2026-07-31 |